Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.320
-0.150 (-6.07%)
At close: Feb 21, 2025, 4:00 PM
2.280
-0.040 (-1.72%)
After-hours: Feb 21, 2025, 7:32 PM EST
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $165.34 million as of February 21, 2025. Its market cap has decreased by -79.81% in one year.
Market Cap
165.34M
Enterprise Value
-182.65M
1-Year Change
-79.81%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has increased from $129.95M to $165.34M, an increase of 27.23%. That is a compound annual growth rate of 5.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 165.34M | -23.43% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 1,523.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |